| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +1068928.21% |
| VRNA | Verona Pharma Plc | $77.75B | +685340.77% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +609127.71% |
| ARGX | Argen X SE | $57.12B | +503514.09% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +325673.18% |
| RVMD | Revolution Medicines Inc | $36.92B | +325404.37% |
| ONC | BeiGene Ltd | $36.03B | +317593.51% |
| MRNA | Moderna Inc | $27.11B | +238883.56% |
| ROIV | Roivant Sciences Ltd | $25.13B | +221479.70% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +216741.41% |
| INSM | Insmed Inc | $23.78B | +209517.53% |
| BNTX | BioNTech SE | $23.26B | +204990.91% |
| INCY | Incyte Corp | $23.01B | +202780.14% |
| GMAB | Genmab | $18.57B | +163610.36% |
| ASND | Ascendis Pharma A/S | $17.33B | +152673.83% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +142522.26% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +130503.15% |
| EXEL | Exelixis Inc | $14.09B | +124148.24% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +111679.63% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +107580.81% |
| SMMT | Summit Therapeutics Inc | $11.69B | +103002.39% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +100345.32% |
| TECH | Bio-Techne Corp | $11.19B | +98534.20% |
| ABVX | Abivax | $10.86B | +95628.06% |
| KRYS | Krystal Biotech Inc | $10.31B | +90795.69% |
| CYTK | Cytokinetics Inc | $10.18B | +89691.90% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +88907.20% |
| APGE | Apogee Therapeutics Inc | $10.06B | +88555.85% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +85875.91% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +82584.29% |
| CORT | Corcept Therapeutics Inc | $9.35B | +82369.36% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +79949.98% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +79126.49% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +78109.21% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +77799.03% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +76603.13% |
| TGTX | TG Therapeutics Inc | $8.64B | +76037.38% |
| PCVX | Vaxcyte Inc | $8.19B | +72091.28% |
| IMVT | Immunovant Inc | $8.13B | +71603.82% |
| IBRX | ImmunityBio Inc | $8.10B | +71275.91% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +70846.01% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +66090.14% |
| MTSR | Metsera Inc | $7.40B | +65181.21% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +64893.99% |
| MRUS | Merus N.V | $6.83B | +60076.96% |
| COGT | Cogent Biosciences Inc | $6.71B | +59069.49% |
| ACLX | Arcellx Inc | $6.67B | +58668.50% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +57579.62% |
| PTCT | PTC Therapeutics Inc | $6.53B | +57509.08% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +57155.12% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +56644.64% |
| CGON | Cg Oncology Inc | $6.42B | +56540.60% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +55147.25% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +52335.47% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +52213.80% |
| BLTE | Belite Bio Inc | $5.88B | +51740.83% |
| ERAS | Erasca Inc | $5.51B | +48446.36% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +47978.22% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +46173.69% |
| TVTX | Travere Therapeutics Inc | $5.24B | +46123.51% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +43552.12% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +43408.92% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +39610.81% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +38996.15% |
| CELC | Celcuity Inc | $4.42B | +38905.48% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +38589.86% |
| VKTX | Viking Therapeutics Inc | $4.38B | +38532.38% |
| AKRO | Akero Therapeutics Inc | $4.38B | +38516.55% |
| TNGX | Tango Therapeutics Inc | $4.36B | +38346.94% |
| ORKA | ARCA biopharma Inc | $4.35B | +38224.46% |
| LEGN | Legend Biotech Corp | $4.26B | +37424.18% |
| DYN | Dyne Therapeutics Inc | $3.96B | +34840.39% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +33820.44% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +33620.43% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +32786.38% |
| RLAY | Relay Therapeutics Inc | $3.69B | +32444.99% |
| DNLI | Denali Therapeutics Inc | $3.65B | +32099.32% |
| ALMS | Alumis Inc | $3.60B | +31662.39% |
| GPCR | Structure Therapeutics Inc | $3.53B | +30990.16% |
| RCUS | Arcus Biosciences Inc | $3.52B | +30902.44% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +30524.72% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +28437.27% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +28357.41% |
| BEAM | Beam Therapeutics Inc | $3.17B | +27834.81% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +27381.08% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +26681.62% |
| IRON | Disc Medicine Inc | $2.90B | +25495.69% |
| MBX | MBX Biosciences Inc | $2.89B | +25346.68% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +24070.45% |
| KOD | Kodiak Sciences Inc | $2.64B | +23145.32% |
| IMNM | Immunome Inc | $2.59B | +22768.37% |
| QURE | uniQure N.V. | $2.58B | +22684.40% |
| CLDX | Celldex Therapeutics Inc | $2.55B | +22383.71% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +21708.99% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +21705.07% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +21339.34% |
| VCEL | Vericel Corp | $2.38B | +20910.78% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +20758.72% |
| MESO | Mesoblast Ltd | $2.36B | +20677.23% |
| ETNB | 89bio Inc | $2.34B | +20555.97% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +20442.03% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +20347.04% |
| PHVS | Pharvaris NV | $2.30B | +20143.29% |
| ZLAB | Zai Lab Ltd | $2.27B | +19906.86% |
| BHVN | Biohaven Ltd | $2.24B | +19631.05% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +19447.55% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +19121.31% |
| PVLA | Palvella Therapeutics Inc | $2.18B | +19077.52% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +18461.85% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +18260.30% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +18208.05% |
| ABCL | AbCellera Biologics Inc | $2.05B | +17960.91% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +17923.70% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +17705.05% |
| ADMA | Adma Biologics Inc | $2.02B | +17675.93% |
| SION | Sionna Therapeutics Inc | $2.00B | +17536.54% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +17303.03% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +17174.72% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +17116.83% |
| URGN | UroGen Pharma Ltd | $1.94B | +16991.09% |
| TYRA | Tyra Biosciences Inc | $1.93B | +16876.83% |
| NBTX | Nanobiotix | $1.91B | +16746.73% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +16729.80% |
| GLPG | Galapagos NV | $1.90B | +16635.60% |
| AAPG | Ascentage Pharma Group International | $1.87B | +16375.18% |
| STOK | Stoke Therapeutics Inc | $1.86B | +16312.41% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +16290.36% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +16147.07% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +16075.13% |
| PGEN | Precigen Inc | $1.82B | +15965.22% |
| ZYME | Zymeworks BC Inc | $1.80B | +15793.17% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +15577.45% |
| IMCR | Immunocore Holdings plc | $1.76B | +15441.74% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +15384.70% |
| FTRE | Fortrea Holdings Inc | $1.69B | +14837.25% |
| NKTR | Nektar Therapeutics | $1.69B | +14794.82% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +14778.74% |
| GHRS | GH Research PLC | $1.67B | +14622.75% |
| ANAB | AnaptysBio Inc | $1.62B | +14186.72% |
| INVA | Innoviva Inc | $1.62B | +14144.04% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +13747.12% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +13692.14% |
| VIR | Vir Biotechnology Inc | $1.55B | +13560.42% |
| SEPN | Septerna Inc | $1.53B | +13391.58% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +13062.04% |
| ABSI | Absci Corp | $1.49B | +13061.85% |
| MAZE | Maze Therapeutics Inc | $1.46B | +12787.50% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +12442.19% |
| NVAX | Novavax Inc | $1.39B | +12120.05% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +12096.52% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +11647.45% |
| ARDX | Ardelyx Inc | $1.31B | +11440.11% |
| IMTX | Immatics N.V | $1.28B | +11141.49% |
| MNKD | Mannkind Corp | $1.26B | +11038.73% |
| ANNX | Annexon Inc | $1.26B | +11028.76% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +10961.13% |
| TRML | Tourmaline Bio Inc | $1.24B | +10794.46% |
| SVRA | Savara Inc | $1.19B | +10396.61% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +10245.66% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +10090.04% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +10063.72% |
| WVE | Wave Life Sciences Ltd | $1.14B | +9921.57% |
| XNCR | Xencor Inc | $1.11B | +9681.44% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +9567.91% |
| CGEM | Cullinan Oncology Inc | $1.10B | +9559.77% |
| JBIO | Jade Biosciences Inc | $1.08B | +9410.12% |
| CVAC | CureVac N.V. | $1.05B | +9150.94% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +9000.80% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +8918.70% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +8704.94% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +8626.92% |
| VOR | Vor Biopharma Inc | $979.68M | +8537.06% |
| JANX | Janux Therapeutics Inc | $975.67M | +8501.78% |
| ANRO | Alto Neuroscience Inc | $973.06M | +8478.78% |
| SANA | Sana Biotechnology Inc | $957.85M | +8344.65% |
| GERN | Geron Corp | $950.51M | +8279.96% |
| SLDB | Solid Biosciences Inc | $946.56M | +8245.09% |
| PHAR | Pharming Group N.V. | $939.88M | +8186.23% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +8156.94% |
| DBVT | DBV Technologies | $930.17M | +8100.57% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +8030.19% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +7817.72% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +7639.24% |
| TBPH | Theravance Biopharma Inc | $872.15M | +7589.09% |
| DSGN | Design Therapeutics Inc | $844.21M | +7342.75% |
| REPL | Replimune Group Inc | $800.70M | +6959.17% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +6794.80% |
| OCS | Oculis Holding AG | $772.84M | +6713.53% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +6654.38% |
| CMRX | Chimerix Inc | $766.03M | +6653.51% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +6584.54% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +6509.69% |
| OMER | Omeros Corporation | $746.63M | +6482.44% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +6319.30% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +6318.77% |
| ATXS | Astria Therapeutics Inc | $709.95M | +6159.11% |
| CADL | Candel Therapeutics Inc | $706.21M | +6126.09% |
| XOMA | XOMA Royalty Corp | $699.64M | +6068.21% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +5838.17% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +5741.21% |
| CRMD | CorMedix Inc | $660.09M | +5719.51% |
| IVA | Inventiva | $655.21M | +5676.54% |
| CTMX | CytomX Therapeutics Inc | $652.36M | +5651.41% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +5642.63% |
| MDXG | Mimedx Group Inc | $635.94M | +5506.58% |
| RGNX | Regenxbio Inc | $633.34M | +5483.69% |
| PRME | Prime Medicine Inc | $630.35M | +5457.31% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +5331.19% |
| TECX | AvroBio Inc | $611.99M | +5295.45% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +5282.61% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +5182.45% |
| IMMX | Immix Biopharma Inc | $558.22M | +4821.38% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +4797.99% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +4716.05% |
| ARVN | Arvinas Inc | $534.06M | +4608.41% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +4481.23% |
| STTK | Shattuck Labs Inc | $511.69M | +4411.18% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +4408.69% |
| VSTM | Verastem Inc | $503.34M | +4337.58% |
| SLN | Silence Therapeutics Plc | $493.60M | +4251.72% |
| OCGN | Ocugen Inc | $483.80M | +4165.27% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +4051.95% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +4000.89% |
| SVA | Sinovac Biotech Ltd | $464.94M | +3999.02% |
| CABA | Cabaletta Bio Inc | $463.15M | +3983.25% |
| RZLT | Rezolute Inc | $456.43M | +3923.96% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +3879.75% |
| EVMN | Evommune Inc | $447.71M | +3847.11% |
| PRTA | Prothena Corporation plc | $447.44M | +3844.75% |
| BNTC | Benitec Biopharma Inc | $447.29M | +3843.45% |
| VALN | Valneva SE | $440.98M | +3787.78% |
| CBIO | N/A | $432.05M | +3709.08% |
| STRO | Sutro Biopharma Inc | $430.74M | +3697.48% |
| AURA | Aura Biosciences Inc | $430.49M | +3695.30% |
| PBYI | Puma Biotechnology Inc | $427.89M | +3672.42% |
| ASMB | Assembly Biosciences Inc | $424.80M | +3645.17% |
| OVID | Ovid Therapeutics Inc | $416.49M | +3571.91% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +3554.83% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +3529.38% |
| CYBN | Cybin Inc | $408.43M | +3500.84% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +3459.68% |
| AUTL | Autolus Therapeutics plc | $401.88M | +3443.05% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +3411.53% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +3389.42% |
| UPB | Upstream Bio Inc | $395.63M | +3388.00% |
| CCCC | C4 Therapeutics Inc | $395.34M | +3385.40% |
| IPSC | Century Therapeutics Inc | $390.82M | +3345.59% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +3340.00% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +3328.92% |
| CMPX | Compass Therapeutics Inc | $385.39M | +3297.68% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +3289.65% |
| RVNC | Revance Therapeutics Inc | $380.38M | +3253.50% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +3223.58% |
| ALT | Altimmune Inc | $373.67M | +3194.41% |
| TENX | Tenax Therapeutics Inc | $372.39M | +3183.05% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +3144.73% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +3143.03% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +3127.93% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +3001.47% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +2996.01% |
| EDIT | Editas Medicine Inc | $349.39M | +2980.27% |
| FATE | Fate Therapeutics Inc | $347.65M | +2965.01% |
| FBRX | Forte Biosciences Inc | $340.15M | +2898.87% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +2898.64% |
| PALI | Palisade Bio Inc | $339.87M | +2896.34% |
| IMAB | I-Mab | $339.64M | +2894.32% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +2885.57% |
| IMRX | Immuneering Corp Class A | $333.64M | +2841.45% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +2832.84% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +2720.96% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +2715.41% |
| ANL | Adlai Nortye Ltd | $317.46M | +2698.77% |
| GALT | Galectin Therapeutics Inc | $313.48M | +2663.71% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +2592.40% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +2589.49% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +2588.29% |
| SCPH | scPharmaceuticals Inc | $304.59M | +2585.35% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +2570.11% |
| OABI | OmniAb Inc | $301.15M | +2555.02% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +2493.42% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +2484.85% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +2426.50% |
| TTRX | Turn Therapeutics Inc | $285.37M | +2415.89% |
| CLLS | Cellectis | $282.48M | +2390.43% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +2333.41% |
| NAGE | Niagen Bioscience Inc | $275.72M | +2330.78% |
| MGNX | Macrogenics Inc | $274.58M | +2320.76% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +2317.38% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +2307.87% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +2297.91% |
| SRZN | Surrozen Inc | $250.37M | +2107.30% |
| IRD | Ocuphire Pharma Inc | $248.48M | +2090.67% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +2084.39% |
| THRD | Third Harmonic Bio Inc | $241.86M | +2032.34% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +1990.55% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +1954.29% |
| ACIU | AC Immune SA | $232.87M | +1953.03% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +1942.54% |
| IVVD | Invivyd Inc | $231.05M | +1937.00% |
| QTTB | Q32 Bio Inc | $229.68M | +1924.94% |
| SLRN | Acelyrin Inc | $228.54M | +1914.90% |
| DTIL | Precision Biosciences Inc | $227.35M | +1904.37% |
| TARA | Protara Therapeutics Inc | $226.83M | +1899.78% |
| CGEN | Compugen Ltd | $223.15M | +1867.31% |
| CHRS | Coherus Biosciences Inc | $222.07M | +1857.85% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +1849.30% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +1827.30% |
| KROS | Keros Therapeutics Inc | $217.65M | +1818.89% |
| ADAG | Adagene Inc | $217.38M | +1816.49% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +1796.42% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +1794.12% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +1786.70% |
| RNA | Atrium Therapeutics Inc | $210.40M | +1754.93% |
| IMUX | Immunic Inc | $205.68M | +1713.37% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +1679.17% |
| CDXS | Codexis Inc | $200.88M | +1670.97% |
| NKTX | Nkarta Inc | $197.53M | +1641.44% |
| AGEN | Agenus Inc | $192.99M | +1601.48% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +1601.48% |
| NERV | Minerva Neurosciences Inc | $189.40M | +1569.78% |
| KRRO | Korro Bio Inc | $187.93M | +1556.80% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +1544.15% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +1540.25% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +1513.14% |
| MDWD | MediWound Ltd | $182.55M | +1509.44% |
| IFRX | InflaRx N.V. | $182.18M | +1506.13% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +1501.97% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +1501.23% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +1494.08% |
| ACOG | Alpha Cognition Inc | $180.73M | +1493.32% |
| MENS | Jyong Biotech Ltd | $174.10M | +1434.95% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +1430.00% |
| PEPG | PepGen Inc | $168.86M | +1388.70% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +1381.60% |
| CRBU | Caribou Biosciences Inc | $167.73M | +1378.71% |
| THTX | Theratechnologies Inc | $167.34M | +1375.28% |
| ALEC | Alector Inc | $166.54M | +1368.24% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +1364.91% |
| EQ | Equillium Inc | $165.65M | +1360.44% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +1354.02% |
| IPHA | Innate Pharma | $164.54M | +1350.64% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +1338.80% |
| YDES | YD Bio Ltd | $160.69M | +1316.70% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +1313.64% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +1309.08% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +1279.38% |
| PYXS | Pyxis Oncology Inc | $152.68M | +1246.06% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +1243.50% |
| HUMA | Humacyte Inc | $151.33M | +1234.15% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +1218.90% |
| NBP | NovaBridge Biosciences. | $149.30M | +1216.25% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +1216.11% |
| AKTX | Akari Therapeutics Plc | $148.12M | +1205.90% |
| MOLN | Molecular Partners AG | $146.63M | +1192.77% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +1191.46% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +1182.90% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +1181.50% |
| HURA | TuHURA Biosciences Inc | $144.96M | +1178.00% |
| GUTS | Fractyl Health Inc | $144.37M | +1172.81% |
| PROK | ProKidney Corp - Class A | $137.85M | +1115.32% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +1113.35% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +1095.67% |
| THAR | Tharimmune Inc | $135.41M | +1093.80% |
| SEER | Seer Inc - Class A | $132.16M | +1065.18% |
| GNLX | Genelux Corp | $130.49M | +1050.39% |
| VXRT | Vaxart Inc | $127.95M | +1028.03% |
| ENGN | enGene Holdings Inc | $127.28M | +1022.13% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +1016.96% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +1007.26% |
| FBIO | Fortress Biotech Inc | $123.12M | +985.48% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +974.32% |
| VANI | Vivani Medical Inc | $119.35M | +952.25% |
| ANIX | Anixa Biosciences Inc | $118.73M | +946.75% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +921.07% |
| SAVA | Cassava Sciences Inc. | $114.97M | +913.63% |
| RPTX | Repare Therapeutics Inc | $113.91M | +904.28% |
| COYA | Coya Therapeutics Inc | $113.53M | +900.93% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +877.04% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +825.53% |
| HLVX | HilleVax Inc | $104.74M | +823.40% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +814.39% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +802.81% |
| SPRO | Spero Therapeutics Inc | $98.42M | +767.66% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +761.70% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +757.22% |
| ICCC | Immucell Corp | $97.07M | +755.81% |
| PYPD | Polypid Ltd | $94.84M | +736.16% |
| BMEA | Biomea Fusion Inc | $93.27M | +722.26% |
| CUE | Cue Biopharma Inc | $92.75M | +717.66% |
| ENLV | Enlivex Ltd | $92.47M | +715.21% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +708.11% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +686.30% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +674.78% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +666.93% |
| CRDF | Cardiff Oncology Inc | $85.46M | +653.46% |
| RLYB | Rallybio Corp | $85.33M | +652.30% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +647.67% |
| LPTX | Leap Therapeutics Inc | $84.76M | +647.25% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +646.39% |
| ACET | Adicet Bio Inc | $83.31M | +634.46% |
| HRTX | Heron Therapeutics Inc | $83.25M | +633.99% |
| ENTX | Entera Bio Ltd | $82.99M | +631.64% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +619.71% |
| CSBR | Champions Oncology Inc | $80.27M | +607.64% |
| NRXS | Neuraxis Inc | $79.92M | +604.61% |
| FBIOP | Fortress Biotech Inc | $77.72M | +585.20% |
| ATHA | Athira Pharma Inc | $77.21M | +580.74% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +558.26% |
| GLTO | Galecto Inc | $74.66M | +558.18% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +555.85% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +541.63% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +534.12% |
| GANX | Gain Therapeutics Inc | $71.38M | +529.31% |
| XBIT | XBiotech Inc | $69.82M | +515.52% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +511.36% |
| HYFT | MindWalk Holdings Corp | $69.31M | +511.04% |
| MNOV | Medicinova Inc | $68.91M | +507.53% |
| SPRB | Spruce Biosciences Inc | $67.96M | +499.11% |
| IMA | Ikena Oncology Inc | $67.49M | +495.03% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +473.53% |
| IMMP | Immutep Ltd | $64.23M | +466.27% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +460.30% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +457.36% |
| EDSA | Edesa Biotech Inc | $61.04M | +438.19% |
| OSTX | OS Therapies Inc | $60.88M | +436.74% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +421.92% |
| IBIO | iBio Inc | $58.38M | +414.68% |
| CNTX | Context Therapeutics Inc | $57.91M | +410.56% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +394.87% |
| BOLD | Boundless Bio Inc | $55.35M | +387.94% |
| INMB | INmune Bio Inc | $55.03M | +385.17% |
| CING | Cingulate Inc | $54.66M | +381.89% |
| KZR | Kezar Life Sciences Inc | $53.76M | +373.95% |
| INKT | MiNK Therapeutics Inc | $53.21M | +369.09% |
| XLO | Xilio Therapeutics Inc | $52.74M | +364.94% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +363.58% |
| ATYR | Atyr Pharma Inc | $52.39M | +361.87% |
| MCRB | Seres Therapeutics Inc | $52.28M | +360.90% |
| BYSI | BeyondSpring Inc | $52.22M | +360.40% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +357.49% |
| RNTX | Rein Therapeutics Inc | $51.79M | +356.63% |
| TIL | Instil Bio Inc | $51.68M | +355.61% |
| ANVS | Annovis Bio Inc | $51.65M | +355.38% |
| GOSS | Gossamer Bio Inc | $51.14M | +350.87% |
| IBO | Impact BioMedical Inc | $50.13M | +341.92% |
| MGX | Metagenomi Inc | $48.56M | +328.16% |
| DWTX | Virios Therapeutics Inc | $48.10M | +324.05% |
| LVTX | LAVA Therapeutics NV | $45.77M | +303.53% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +303.14% |
| DYAI | Dyadic International Inc DE | $44.46M | +291.93% |
| PDSB | PDS Biotechnology Corporation | $41.64M | +267.10% |
| APLM | Apollomics Inc - Class A | $41.33M | +264.39% |
| ACTU | Actuate Therapeutics Inc | $40.78M | +259.56% |
| FGEN | FibroGen Inc | $39.31M | +246.53% |
| GRCE | Acasti Pharma Inc | $38.94M | +243.29% |
| VERU | Veru Inc | $38.84M | +242.44% |
| RNXT | RenovoRx Inc | $38.73M | +241.43% |
| NNVC | NanoViricides Inc | $37.23M | +228.25% |
| NTRB | Nutriband Inc | $37.08M | +226.87% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +218.31% |
| GBIO | Generation Bio Company | $35.97M | +217.11% |
| GNTA | Genenta Science SpA | $35.85M | +216.07% |
| ALGS | Aligos Therapeutics Inc | $35.71M | +214.79% |
| MURA | Mural Oncology plc | $35.34M | +211.59% |
| LTRN | Lantern Pharma Inc | $34.89M | +207.60% |
| LITS | Lite Strategy Inc | $34.77M | +206.57% |
| HYPD | Eyenovia Inc | $34.51M | +204.28% |
| LSTA | Lisata Therapeutics Inc | $34.15M | +201.10% |
| ABVC | ABVC BioPharma Inc | $32.98M | +190.78% |
| ESLA | Estrella Immunopharma Inc | $32.50M | +186.57% |
| SNTI | Senti Biosciences Inc | $32.39M | +185.56% |
| DARE | Dare Bioscience Inc | $30.14M | +165.71% |
| SER | AgeX Therapeutics Inc | $29.05M | +156.14% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | +154.19% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | +151.85% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | +151.80% |
| CRVO | CervoMed Inc | $28.42M | +150.60% |
| PSTV | Plus Therapeutics Inc | $28.00M | +146.83% |
| TVRD | Cara Therapeutics Inc | $27.49M | +142.34% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | +133.08% |
| IGC | IGC Pharma Inc | $26.36M | +132.39% |
| EVAX | Evaxion Biotech A/S | $25.44M | +124.26% |
| VYNE | VYNE Therapeutics Inc | $25.25M | +122.65% |
| GRDX | Entero Therapeutics Inc | $24.74M | +118.10% |
| NXTC | Nextcure Inc | $23.92M | +110.87% |
| MRKR | Marker Therapeutics Inc | $23.55M | +107.60% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | +106.35% |
| CELU | Celularity Inc - Class A | $22.49M | +98.31% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +93.57% |
| OPT | Opthea Ltd | $21.53M | +89.81% |
| SKYE | Skye Bioscience Inc | $21.29M | +87.70% |
| PLRZ | Polyrizon Ltd | $21.02M | +85.32% |
| ATOS | Atossa Therapeutics Inc | $21.01M | +85.24% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +79.64% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | +75.68% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | +71.70% |
| JSPR | Jasper Therapeutics Inc | $19.37M | +70.80% |
| KALA | Kala Bio Inc | $19.15M | +68.81% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | +66.88% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | +66.22% |
| ALLR | Allarity Therapeutics Inc | $18.67M | +64.57% |
| ICU | SeaStar Medical Holding Corp | $18.45M | +62.67% |
| PLUR | Pluri Inc | $18.25M | +60.93% |
| LPCN | Lipocine Inc | $17.64M | +55.53% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | +54.76% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | +45.46% |
| HIND | ReShape Lifesciences Inc | $15.93M | +40.46% |
| PTN | Palatin Technologies Inc | $15.81M | +39.37% |
| PASG | Passage Bio Inc | $15.75M | +38.86% |
| LGVN | Longeveron Inc - Class A | $15.75M | +38.83% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | +38.72% |
| TPST | Tempest Therapeutics Inc | $15.35M | +35.31% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +31.96% |
| APLT | Applied Therapeutics Inc | $14.86M | +31.04% |
| HOTH | Hoth Therapeutics Inc | $14.64M | +29.10% |
| LEXX | Lexaria Bioscience Corp | $14.58M | +28.52% |
| IOBT | IO Biotech Inc | $14.50M | +27.82% |
| HOOK | Hookipa Pharma Inc | $14.43M | +27.19% |
| INAB | IN8bio Inc | $14.18M | +25.01% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | +23.42% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | +21.85% |
| BIVI | BioVie Inc - Class A | $13.35M | +17.69% |
| BLRX | Bioline Rx Ltd | $13.35M | +17.66% |
| LNAI | Lunai Bioworks Inc | $13.33M | +17.48% |
| COCP | Cocrystal Pharma Inc | $13.24M | +16.69% |
| QNCX | Quince Therapeutics Inc | $13.03M | +14.91% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +14.79% |
| GTBP | GT Biopharma Inc | $12.33M | +8.68% |
| MBRX | Moleculin Biotech Inc | $12.33M | +8.68% |
| CALC | CalciMedica Inc | $12.31M | +8.49% |
| INTS | Intensity Therapeutics Inc | $12.30M | +8.41% |
| AIM | AIM ImmunoTech Inc. | $12.01M | +5.88% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | +5.08% |
| CTXR | Citius Pharmaceuticals Inc | $11.88M | +4.77% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | -0.19% |
| TOVX | Theriva Biologics Inc | $11.15M | -1.72% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | -3.62% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | -5.37% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -8.08% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | -8.84% |
| XCUR | Exicure Inc | $10.33M | -8.97% |
| CVM | Cel-Sci Corp | $10.15M | -10.55% |
| MLEC | Moolec Science SA | $10.06M | -11.33% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | -12.69% |
| BCDA | BioCardia Inc | $9.59M | -15.49% |
| MTVA | MetaVia Inc | $9.55M | -15.77% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | -16.45% |
| CRIS | Curis Inc | $9.45M | -16.64% |
| TRAW | Traws Pharma Inc | $9.16M | -19.23% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | -20.39% |
| EPIX | Essa Pharma Inc | $8.93M | -21.26% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -21.38% |
| IMNN | Imunon Inc | $8.71M | -23.24% |
| BRTX | BioRestorative Therapies Inc | $8.66M | -23.63% |
| APRE | Aprea Therapeutics Inc | $8.48M | -25.25% |
| ADXN | Addex Therapeutics Ltd | $8.21M | -27.66% |
| SYBX | Synlogic Inc | $8.20M | -27.68% |
| IMRN | Immuron Ltd | $8.15M | -28.13% |
| BOLT | Bolt Biotherapeutics Inc | $8.09M | -28.68% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -28.93% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | -29.71% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | -30.82% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | -33.24% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | -34.01% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -35.33% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | -35.55% |
| BCAB | BioAtla Inc | $7.07M | -37.67% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | -39.39% |
| KAPA | Kairos Pharma Ltd | $6.75M | -40.50% |
| XBIO | Xenetic Biosciences Inc | $6.65M | -41.36% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | -42.90% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -43.58% |
| GOVX | Geovax Labs Inc | $6.29M | -44.59% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | -46.16% |
| PPBT | Purple Biotech Ltd | $6.05M | -46.67% |
| HCWB | HCW Biologics Inc | $6.02M | -46.90% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | -46.99% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | -47.71% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | -48.06% |
| PULM | Pulmatrix Inc | $5.73M | -49.45% |
| EVGN | Evogene Ltd | $5.64M | -50.25% |
| APVO | Aptevo Therapeutics Inc | $5.50M | -51.50% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | -53.30% |
| SILO | SILO Pharma Inc | $5.29M | -53.37% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -53.90% |
| LIMN | Liminatus Pharma Inc | $5.14M | -54.70% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | -55.34% |
| BGMS | Bio Green Med Solution Inc | $5.00M | -55.94% |
| NCNA | NuCana plc | $4.99M | -56.00% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -56.72% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.80M | -57.71% |
| ALZN | Alzamend Neuro Inc | $4.68M | -58.74% |
| GNPX | Genprex Inc | $4.44M | -60.85% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -62.40% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -62.41% |
| REVB | Revelation Biosciences Inc | $4.26M | -62.44% |
| MBIO | Mustang Bio Inc | $4.25M | -62.50% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | -62.61% |
| ENVB | Enveric Biosciences Inc | $4.15M | -63.39% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -63.51% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | -63.97% |
| SNGX | Soligenix Inc | $3.91M | -65.50% |
| PBM | Psyence Biomedical Ltd | $3.76M | -66.82% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | -67.41% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | -70.21% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -70.54% |
| FBLG | FibroBiologics Inc | $3.18M | -71.97% |
| SLXN | Silexion Therapeutics Corp | $3.11M | -72.58% |
| SPRC | SciSparc Ltd | $3.05M | -73.15% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | -73.71% |
| AFMD | Affimed N.V. | $2.98M | -73.77% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -74.64% |
| ARTL | Artelo Biosciences Inc | $2.75M | -75.79% |
| GRI | GRI Bio Inc | $2.57M | -77.36% |
| ONCO | Onconetix Inc | $2.54M | -77.61% |
| PPCB | Propanc Biopharma Inc | $2.50M | -77.94% |
| VIVS | VivoSim Labs Inc | $2.47M | -78.24% |
| OGEN | Oragenics Inc | $2.45M | -78.40% |
| NBY | Stablecoin Development Corp | $2.40M | -78.80% |
| NTBL | Notable Labs Inc Ord | $2.39M | -78.89% |
| BBLG | Bone Biologics Corp | $2.23M | -80.37% |
| AZTR | Azitra Inc | $2.22M | -80.40% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | -80.76% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -81.08% |
| CMND | Clearmind Medicine Inc | $2.12M | -81.35% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -81.59% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -82.42% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -86.26% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -86.60% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -87.42% |
| JAGX | Jaguar Health Inc | $1.34M | -88.15% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -90.92% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -91.83% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -91.96% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -95.14% |
| PTIX | Protagenic Therapeutics Inc | $503648.74 | -95.56% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -96.06% |
| ELAB | PMGC Holdings Inc | $221376.00 | -98.05% |
| CDT | CDT Equity Inc | $110551.31 | -99.03% |
| ADTX | Aditxt Inc | $98471.97 | -99.13% |